OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
15
Results
Show all
Save search
Copy query
Show results for
Unknown
(15)
Publication Date
Release Date
2025
(4)
2023
(2)
2014
(2)
2012
(2)
2011
(2)
2024
(1)
2013
(1)
2009
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.
Not available
S-EPMC4121503
|
biostudies-literature
Cite
Active idiotypic vaccination versus control immunotherapy for follicular lymphoma.
Not available
S-EPMC4039868
|
biostudies-literature
Cite
Donepezil delays progression to AD in MCI subjects with depressive symptoms.
Not available
S-EPMC2697965
|
biostudies-literature
Cite
Results of the two incidence screenings in the National Lung Screening Trial.
Not available
S-EPMC4307922
|
biostudies-literature
Cite
Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension.
Not available
S-EPMC12087357
|
biostudies-literature
Cite
Common variants at 12q14 and 12q24 are associated with hippocampal volume.
Not available
S-EPMC3427729
|
biostudies-literature
Cite
Identification of common variants associated with human hippocampal and intracranial volumes.
Not available
S-EPMC3635491
|
biostudies-literature
Cite
Prehospital cardiac arrest resuscitation practices differ around the globe.
Not available
S-EPMC12329125
|
biostudies-literature
Cite
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization.
Not available
S-EPMC10064277
|
biostudies-literature
Cite
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
Not available
S-EPMC7615263
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets